Targeted anticoagulant reversal, unintended consequences: lessons from andexanet alfa

European Heart Journal - Cardiovascular Pharmacotherapy

13 March 2026
Organised by: Logo
ESC Journals

Contributors

Jerrold H Levy
Jerrold H Levy

Author

Duke University Health System Durham , United States of America

ESC 365 is supported by